Baudax Bio Inc
BXRX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$174.26K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $174,259.00 |
|---|---|
| Enterprise Value | $11.44 Million |
| Earnings per Share | $-177.3 |
| Beta | 1.58 |
| Outstanding Shares | 7,993,522 |
Return
| Return on Equity | 69.89% |
|---|---|
| Return on Assets | -34.76% |
| Return on Invested Capital | -998.24% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 35.19 |
| Enterprise Value to EBIT | -0.75 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.02 |
| Debt to Equity | -1.14 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Baudax Bio, Inc.
9 employees
CEO: Geraldine A. Henwood
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or ...